CytoSorbents announced that its Chairman of the Board, Al Kraus, will retire at the end of his term in early June 2023.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CTSO:
- CytoSorbents Announces Board Chairman Al W. Kraus To Retire
- CytoSorbents announces study on CytoSorb hemoperfusion
- Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
- CytoSorbents highlights new data to prevent endothelial damage to blood vessels
- CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)